IL18 and systemic lupus erythematosus: The activation of spinal GPR109A with MK1903 resulted in the attenuation of p38 MAPK activity and glutamatergic synaptic activity by suppressing the production of IL-18 and IL-1β in the spinal dorsal horn of lupus mice with chronic pain.